PRKG1 and depressive symptom measurement: The resulting NO increase in neurons activates cGMP and protein kinase G (PKG) signaling and affects multiple cellular processes, including neurotransmission, cell metabolism, long-term potentiation and depression, and neuropathic pain [57].